289 related articles for article (PubMed ID: 25155800)
21. Changes in mitral regurgitation after replacement of the stenotic aortic valve.
Waisbren EC; Stevens LM; Avery EG; Picard MH; Vlahakes GJ; Agnihotri AK
Ann Thorac Surg; 2008 Jul; 86(1):56-62. PubMed ID: 18573398
[TBL] [Abstract][Full Text] [Related]
22. Transapical versus transfemoral aortic valve implantation: a multicenter collaborative study.
van der Boon RM; Marcheix B; Tchetche D; Chieffo A; Van Mieghem NM; Dumonteil N; Vahdat O; Maisano F; Serruys PW; Kappetein AP; Fajadet J; Colombo A; Carrié D; van Domburg RT; de Jaegere PP
Ann Thorac Surg; 2014 Jan; 97(1):22-8. PubMed ID: 24263012
[TBL] [Abstract][Full Text] [Related]
23. Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre.
Kaya D; Tanriverdi Z; Dursun H; Colluoglu T
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1371-1378. PubMed ID: 27278270
[TBL] [Abstract][Full Text] [Related]
24. Prospective evaluation of clinical outcomes in all-comer high-risk patients with aortic valve stenosis undergoing medical treatment, transcatheter or surgical aortic valve implantation following heart team assessment.
Dubois C; Coosemans M; Rega F; Poortmans G; Belmans A; Adriaenssens T; Herregods MC; Goetschalckx K; Desmet W; Janssens S; Meyns B; Herijgers P
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):492-500. PubMed ID: 23702465
[TBL] [Abstract][Full Text] [Related]
25. Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry.
Murdoch DJ; Sathananthan J; Hensey M; Alu MC; Liu Y; Crowley A; Wood D; Cheung A; Ye J; Feldman T; Hahn RT; Jaber WA; Mack MJ; Malaisrie SC; Leon MB; Webb JG
Catheter Cardiovasc Interv; 2020 Oct; 96(4):981-986. PubMed ID: 32118351
[TBL] [Abstract][Full Text] [Related]
26. Clinical Impact of Preprocedural Moderate or Severe Mitral Regurgitation on Outcomes After Transcatheter Aortic Valve Replacement.
Miura M; Yamaji K; Shirai S; Hayashi M; Kawaguchi T; Arai Y; Sakaguchi G; Ando K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
Can J Cardiol; 2020 Jul; 36(7):1112-1120. PubMed ID: 32470334
[TBL] [Abstract][Full Text] [Related]
27. Effect of aortic valve replacement for aortic stenosis on severity of mitral regurgitation.
Vanden Eynden F; Bouchard D; El-Hamamsy I; Butnaru A; Demers P; Carrier M; Perrault LP; Tardif JC; Pellerin M
Ann Thorac Surg; 2007 Apr; 83(4):1279-84. PubMed ID: 17383327
[TBL] [Abstract][Full Text] [Related]
28. Influence of CoreValve ReValving System implantation on mitral valve function: an echocardiographic study in selected patients.
De Chiara B; Moreo A; De Marco F; Musca F; Oreglia J; Lobiati E; Bruschi G; Belli O; Mauri F; Klugmann S
Catheter Cardiovasc Interv; 2011 Oct; 78(4):638-44. PubMed ID: 21805556
[TBL] [Abstract][Full Text] [Related]
29. Prognostic benefit of transcatheter aortic valve implantation compared with medical therapy in patients with inoperable aortic stenosis.
Rajani R; Buxton W; Haworth P; Khawaja MZ; Sohal M; Brum RL; Hutchinson N; de Belder A; Trivedi U; Hildick-Smith D
Catheter Cardiovasc Interv; 2010 Jun; 75(7):1121-6. PubMed ID: 20146205
[TBL] [Abstract][Full Text] [Related]
30. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
[TBL] [Abstract][Full Text] [Related]
31. Transaortic Transcatheter Aortic valve implantation using Edwards Sapien valve: a novel approach.
Bapat V; Khawaja MZ; Attia R; Narayana A; Wilson K; Macgillivray K; Young C; Hancock J; Redwood S; Thomas M
Catheter Cardiovasc Interv; 2012 Apr; 79(5):733-40. PubMed ID: 21805602
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome following Transcatheter Aortic Valve Implantation in patients with impaired left ventricular systolic function.
van der Boon RM; Nuis RJ; Van Mieghem NM; Benitez LM; van Geuns RJ; Galema TW; van Domburg RT; Geleijnse ML; Dager A; de Jaegere PP
Catheter Cardiovasc Interv; 2012 Apr; 79(5):702-10. PubMed ID: 22121094
[TBL] [Abstract][Full Text] [Related]
33. Left ventricular remodelling patterns after MitraClip implantation in patients with severe mitral valve regurgitation: mechanistic insights and prognostic implications.
Brouwer HJ; Den Heijer MC; Paelinck BP; Debonnaire P; Vanderheyden M; Van De Heyning CM; De Bock D; Coussement P; Saad G; Ferdinande B; Pouleur AC; Claeys MJ
Eur Heart J Cardiovasc Imaging; 2019 Mar; 20(3):307-313. PubMed ID: 30007315
[TBL] [Abstract][Full Text] [Related]
34. Patient-prosthesis mismatch after transapical aortic valve implantation: incidence and impact on survival.
Kukucka M; Pasic M; Dreysse S; Mladenow A; Habazettl H; Hetzer R; Unbehaun A
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):391-7. PubMed ID: 22329976
[TBL] [Abstract][Full Text] [Related]
35. Impact of valvuloarterial impedance on 2-year outcome of patients undergoing transcatheter aortic valve implantation.
Katsanos S; Yiu KH; Clavel MA; Rodés-Cabau J; Leong D; van der Kley F; Ajmone Marsan N; Bax JJ; Pibarot P; Delgado V
J Am Soc Echocardiogr; 2013 Jul; 26(7):691-8. PubMed ID: 23669595
[TBL] [Abstract][Full Text] [Related]
36. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction.
Clavel MA; Webb JG; Rodés-Cabau J; Masson JB; Dumont E; De Larochellière R; Doyle D; Bergeron S; Baumgartner H; Burwash IG; Dumesnil JG; Mundigler G; Moss R; Kempny A; Bagur R; Bergler-Klein J; Gurvitch R; Mathieu P; Pibarot P
Circulation; 2010 Nov; 122(19):1928-36. PubMed ID: 20975002
[TBL] [Abstract][Full Text] [Related]
37. The beneficial effects of TAVI in mitral insufficiency.
Costantino MF; Dores E; Innelli P; Matera A; Santillo V; Violini R; Fiorilli R; Cappabianca G; Marraudino N; Picano E; Tarsia G
Cardiovasc Ultrasound; 2015 Dec; 13():49. PubMed ID: 26714887
[TBL] [Abstract][Full Text] [Related]
38. Impact of Transcatheter Aortic Valve Implantation Among Patients With Co-existing Mild to Moderate Mitral Regurgitation.
Twing AH; Gokhale S; Slostad B; Meyer J; Simon E; Dickens H; Kaluzna SD; Groo V; Kansal M; Shroff A; Groves EM
Am J Cardiol; 2022 Aug; 177():84-89. PubMed ID: 35732551
[TBL] [Abstract][Full Text] [Related]
39. Transapical aortic valve implantation in patients with previous cardiac surgery.
Papadopoulos N; Ilioska P; Fichtlscherer S; Lehmann R; Beiras Fernandez A; Moritz A; Doss M; Zierer A
Ann Thorac Surg; 2014 Jan; 97(1):37-42. PubMed ID: 24075497
[TBL] [Abstract][Full Text] [Related]
40. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
